These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 27031922)

  • 21. Elucidation of two major aggregation pathways in an IgG2 antibody.
    Van Buren N; Rehder D; Gadgil H; Matsumura M; Jacob J
    J Pharm Sci; 2009 Sep; 98(9):3013-30. PubMed ID: 18680168
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A thermal-cycling method for disaggregating monoclonal antibody oligomers.
    Sadavarte RH; Ghosh R
    J Pharm Sci; 2014 Mar; 103(3):870-8. PubMed ID: 24549731
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hydrogen exchange mass spectrometry reveals protein interfaces and distant dynamic coupling effects during the reversible self-association of an IgG1 monoclonal antibody.
    Arora J; Hickey JM; Majumdar R; Esfandiary R; Bishop SM; Samra HS; Middaugh CR; Weis DD; Volkin DB
    MAbs; 2015; 7(3):525-39. PubMed ID: 25875351
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Isotonic concentrations of excipients control the dimerization rate of a therapeutic immunoglobulin G1 antibody during refrigerated storage based on their rank order of native-state interaction.
    Banks DD; Cordia JF; Spasojevic V; Sun J; Franc S; Cho Y
    Protein Sci; 2018 Dec; 27(12):2073-2083. PubMed ID: 30267438
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Highly viscous antibody solutions are a consequence of network formation caused by domain-domain electrostatic complementarities: insights from coarse-grained simulations.
    Buck PM; Chaudhri A; Kumar S; Singh SK
    Mol Pharm; 2015 Jan; 12(1):127-39. PubMed ID: 25383990
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Probing Conformational Diversity of Fc Domains in Aggregation-Prone Monoclonal Antibodies.
    Majumder S; Jones MT; Kimmel M; Alphonse Ignatius A
    Pharm Res; 2018 Sep; 35(11):220. PubMed ID: 30255351
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Correlations between changes in conformational dynamics and physical stability in a mutant IgG1 mAb engineered for extended serum half-life.
    Majumdar R; Esfandiary R; Bishop SM; Samra HS; Middaugh CR; Volkin DB; Weis DD
    MAbs; 2015; 7(1):84-95. PubMed ID: 25524268
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Flexibility of human IgG subclasses.
    Roux KH; Strelets L; Michaelsen TE
    J Immunol; 1997 Oct; 159(7):3372-82. PubMed ID: 9317136
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Viscosity-Lowering Effect of Amino Acids and Salts on Highly Concentrated Solutions of Two IgG1 Monoclonal Antibodies.
    Wang S; Zhang N; Hu T; Dai W; Feng X; Zhang X; Qian F
    Mol Pharm; 2015 Dec; 12(12):4478-87. PubMed ID: 26528726
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Investigating monoclonal antibody aggregation using a combination of H/DX-MS and other biophysical measurements.
    Iacob RE; Bou-Assaf GM; Makowski L; Engen JR; Berkowitz SA; Houde D
    J Pharm Sci; 2013 Dec; 102(12):4315-29. PubMed ID: 24136070
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Emerging methods for identifying monoclonal antibodies with low propensity to self-associate during the early discovery process.
    Tessier PM; Wu J; Dickinson CD
    Expert Opin Drug Deliv; 2014 Apr; 11(4):461-5. PubMed ID: 24444112
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Glycosylation influences on the aggregation propensity of therapeutic monoclonal antibodies.
    Kayser V; Chennamsetty N; Voynov V; Forrer K; Helk B; Trout BL
    Biotechnol J; 2011 Jan; 6(1):38-44. PubMed ID: 20949542
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mechanism and evolution of protein dimerization.
    Xu D; Tsai CJ; Nussinov R
    Protein Sci; 1998 Mar; 7(3):533-44. PubMed ID: 9541384
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A conformationally sensitive GHR [growth hormone (GH) receptor] antibody: impact on GH signaling and GHR proteolysis.
    Jiang J; Wang X; He K; Li X; Chen C; Sayeski PP; Waters MJ; Frank SJ
    Mol Endocrinol; 2004 Dec; 18(12):2981-96. PubMed ID: 15345746
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Utility of High Resolution 2D NMR Fingerprinting in Assessing Viscosity of Therapeutic Monoclonal Antibodies.
    Majumder S; Bhattacharya DS; Langford A; Ignatius AA
    Pharm Res; 2022 Mar; 39(3):529-539. PubMed ID: 35174433
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of Hierarchical Cluster Formation on the Viscosity of Concentrated Monoclonal Antibody Formulations Studied by Neutron Scattering.
    Godfrin PD; Zarraga IE; Zarzar J; Porcar L; Falus P; Wagner NJ; Liu Y
    J Phys Chem B; 2016 Jan; 120(2):278-91. PubMed ID: 26707135
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biophysical Characterization of Binary Therapeutic Monoclonal Antibody Mixtures.
    Krieg D; Berner C; Winter G; Svilenov HL
    Mol Pharm; 2020 Aug; 17(8):2971-2986. PubMed ID: 32687367
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Monoclonal Antibody Dimers Induced by Low pH, Heat, or Light Exposure Are Not Immunogenic Upon Subcutaneous Administration in a Mouse Model.
    Kijanka G; Bee JS; Schenerman MA; Korman SA; Wu Y; Slütter B; Jiskoot W
    J Pharm Sci; 2020 Jan; 109(1):730-738. PubMed ID: 31029572
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluating the Role of the Air-Solution Interface on the Mechanism of Subvisible Particle Formation Caused by Mechanical Agitation for an IgG1 mAb.
    Ghazvini S; Kalonia C; Volkin DB; Dhar P
    J Pharm Sci; 2016 May; 105(5):1643-1656. PubMed ID: 27025981
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High-throughput assay for measuring monoclonal antibody self-association and aggregation in serum.
    Li X; Geng SB; Chiu ML; Saro D; Tessier PM
    Bioconjug Chem; 2015 Mar; 26(3):520-8. PubMed ID: 25714504
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.